Catalyst Pharmaceuticals Inc (CPRX)
21.94
-0.86
(-3.75%)
USD |
NASDAQ |
Nov 14, 11:22
Catalyst Pharmaceuticals Total Return Level: 22.80 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 22.80 |
November 12, 2024 | 23.04 |
November 11, 2024 | 23.45 |
November 08, 2024 | 23.93 |
November 07, 2024 | 23.25 |
November 06, 2024 | 22.71 |
November 05, 2024 | 21.96 |
November 04, 2024 | 21.75 |
November 01, 2024 | 21.89 |
October 31, 2024 | 21.80 |
October 30, 2024 | 21.56 |
October 29, 2024 | 21.77 |
October 28, 2024 | 21.86 |
October 25, 2024 | 21.46 |
October 24, 2024 | 21.41 |
October 23, 2024 | 21.34 |
October 22, 2024 | 21.46 |
October 21, 2024 | 21.02 |
October 18, 2024 | 21.24 |
October 17, 2024 | 21.16 |
October 16, 2024 | 21.67 |
October 15, 2024 | 21.18 |
October 14, 2024 | 20.64 |
October 11, 2024 | 20.20 |
October 10, 2024 | 19.91 |
Date | Value |
---|---|
October 09, 2024 | 19.97 |
October 08, 2024 | 20.08 |
October 07, 2024 | 19.73 |
October 04, 2024 | 20.00 |
October 03, 2024 | 19.88 |
October 02, 2024 | 20.00 |
October 01, 2024 | 20.22 |
September 30, 2024 | 19.88 |
September 27, 2024 | 19.56 |
September 26, 2024 | 19.95 |
September 25, 2024 | 20.00 |
September 24, 2024 | 20.50 |
September 23, 2024 | 20.49 |
September 20, 2024 | 20.79 |
September 19, 2024 | 21.35 |
September 18, 2024 | 20.43 |
September 17, 2024 | 20.44 |
September 16, 2024 | 20.44 |
September 13, 2024 | 20.22 |
September 12, 2024 | 20.29 |
September 11, 2024 | 19.46 |
September 10, 2024 | 19.37 |
September 09, 2024 | 19.65 |
September 06, 2024 | 19.60 |
September 05, 2024 | 19.82 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.61
Minimum
Mar 16 2020
23.93
Maximum
Nov 08 2024
9.929
Average
7.79
Median
Mar 01 2022
Total Return Level Benchmarks
Corcept Therapeutics Inc | 56.43 |
Sarepta Therapeutics Inc | 112.48 |
Alnylam Pharmaceuticals Inc | 264.47 |
Biomarin Pharmaceutical Inc | 66.66 |
Cytokinetics Inc | 55.95 |